https://www.avient.com/investor-center/news/avient-announces-second-quarter-2020-results
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's color and additive masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's color and additive masterbatch business and achieve the expected results of the acquisition of Clariant's color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2022-results
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; any material adverse changes in the Dyneema Business; our ability to achieve the strategic and other objectives relating to the Dyneema Acquisition, and the possible sale of the Distribution business segment; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions.
https://www.avient.com/sites/default/files/2020-10/tpe-injection-molding-guide.pdf
Anisotropy is caused when the polymer chains orient in the direction of flow, which leads to higher physical properties in the flow direction.
https://www.avient.com/sites/default/files/2020-10/tpe-overmold-design-guide.pdf
• The more polymer on the substrate surface, the better the adhesion. • Ensure that the chosen TPE is designed to bond to the substrate. • Appropriate TPE thickness — too thin can lead to delamination. • Use of mechanical interlocks in the component design. • Proper shut-off design. • Adequate venting is critical, especially at ends of flow. • Type of color concentrate carrier used in both the plastic and the TPE. • Pre-drying of the TPE overmold material, if required. • Substrate preparation and cleanliness. • Higher TPE melt temperature generally provides higher bond strength. • Control melt temperature by injection speed, 1st stage pressure, then barrel temps (to fine-tune). 2322 TPE Injection Molding Troubleshooting Problem: Beach marks and uneven shine Possible Cause High molecular weight formulations in highly polished mold.
Additional Factors that Affect Adhesion • Grade of plastic substrate (glass-filled, mineral-filled, heat-stabilized, lubricated). • The more polymer on the substrate surface, the better the adhesion. • Ensure that the chosen TPE is designed to bond to the substrate. • Appropriate TPE thickness — too thin can lead to delamination. • Use of mechanical interlocks in the component design. • Proper shut-off design. • Adequate venting is critical, especially at ends of flow. • Type of color concentrate carrier used in both the plastic and the TPE. • Pre-drying of the TPE overmold material, if required. • Substrate preparation and cleanliness. • Higher TPE melt temperature generally provides higher bond strength. • Control melt temperature by injection speed, 1st stage pressure, then barrel temps (to fine-tune). 2524 Problem: Jetting Possible Cause High viscosity flow.
https://www.avient.com/sites/default/files/resources/PolyOne%25202018%2520Proxy%2520Statement.PDF
Our mission is to become the world’s premier provider of specialized polymer materials, services and solutions, as we execute our proven four-pillar strategy of Specialization, Globalization, Commercial Excellence and Operational Excellence.
Lin also serves as a director for two other public companies and one privately-held biomedical polymer company, which provides her with additional experience she utilizes while serving as a valued member of our Board. �� Current Directorships: WESCO International, Inc.; American Electric Power Company, Inc.; and Interface Biologics Inc.
Nominees for election to the Board are selected on the basis of the following criteria: Business or professional experience; Knowledge and skill in certain specialty areas such as accounting and finance, international markets, physical sciences and technology or the polymer or chemical industry; Personal characteristics such as ethical standards, integrity, judgment, leadership and the ability to devote sufficient time to our affairs; Substantial accomplishments with demonstrated leadership capabilities; Freedom from outside interests that conflict with our best interests; The diversity of backgrounds and experience each member will bring to the Board; and Our needs from time to time.
https://www.avient.com/sites/default/files/2024-05/Responsible Care_14001 Global Cert_Avient_2024.pdf
Design and Manufacture of Colorants and Compounds for Fluoropolymer and High Temperature Polymers. 65536-110437Certificate No: Page 9 of 53 ABS Quality Evaluations ABS Quality Evaluations, Inc. 1701 City Plaza Drive, Spring, TX 77389, U.S.A.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
Lin also serves as a director for two other public companies and one privately-held biomedical polymer company, which provides her with additional experience she utilizes while serving as a valued member of our Board.
Nominees for election to the Board are selected on the basis of the following criteria: ● Business or professional experience; ● Knowledge and skill in certain specialty areas such as accounting and finance, international markets, physical sciences and technology or the polymer or chemical industry; ● Personal characteristics such as ethical standards, integrity, judgment, leadership and the ability to devote sufficient time to our affairs; ● Substantial accomplishments with demonstrated leadership capabilities; ● Freedom from outside interests that conflict with our best interests; ● The diversity of backgrounds and experience each member will bring to the Board; and ● Our needs from time to time.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
She has a deep understanding fof the specialty ctt hemicals industry, a strong operational foundation and wide-ranging international experience. .Ms Lin also serves as a director forff two other public companiess and one privately-held biomedical polymer company, whi hch provides her with additional experience she utilizes whi ele serving as a valued member of our Board.
Nominees for election to the Board are selected on the basis of the folff lowing criteria: ● Business or professional experience; ● Knowledge and skill in certain specialty areas such as accounting and finance, international markets, physical sciences and technology or the polymer or chemical industry; ● Personal characteristics such as ethical standards, integrity, judgment, leadership and the ability to devote sufficient time to our affaff irs; ● Substantial accomplishments with demonstrated leadership capabilities; ● Freedom froff m outside interests that conflict with our best interests; ● The diversity of backgrounds and experience each member will bring to the Board; and ● Our needs from time to time.
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
Lin also currently serves as a director for two other public companies, one privately-held precision engineered drug delivery company, and one privately-held biomedical polymer company, which provides her with additional experience she utilizes while serving as a valued member of our Board.